日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Discovery of a Novel Antimetastatic Bcl3 Inhibitor

新型抗转移 Bcl3 抑制剂的发现

Jitka Soukupová, Cinzia Bordoni, Daniel J Turnham, William W Yang, Gillian Seaton, Aleksandra Gruca, Rhiannon French, Kok Yung Lee, Athina Varnava, Luke Piggott, Richard W E Clarkson, Andrew D Westwell, Andrea Brancale

Efficient Intravenous Tumor Targeting Using the αvβ6 Integrin-Selective Precision Virotherapy Ad5NULL-A20

使用 αvβ6 整合素选择性精准病毒疗法 Ad5NULL-A20 进行有效的静脉肿瘤靶向治疗

James A Davies, Gareth Marlow, Hanni K Uusi-Kerttula, Gillian Seaton, Luke Piggott, Luned M Badder, Richard W E Clarkson, John D Chester, Alan L Parker

Antibody drug conjugates against the receptor for advanced glycation end products (RAGE), a novel therapeutic target in endometrial cancer

针对晚期糖基化终产物受体 (RAGE) 的抗体药物偶联物,这是子宫内膜癌的一种新治疗靶点

Gareth D Healey, Belen Pan-Castillo, Jezabel Garcia-Parra, Julia Davies, Shaun Roberts, Eilir Jones, Kalyan Dhar, Sarika Nandanan, Nasima Tofazzal, Luke Piggott, Richard Clarkson, Gillian Seaton, Asa Frostell, Tim Fagge, Colin McKee, Lavinia Margarit, R Steven Conlan, Deyarina Gonzalez

Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP

ER 阳性乳腺癌对内分泌治疗的获得性耐药性通过 c-FLIP 的翻译后下调赋予对 TRAIL 的适应性敏感性

Luke Piggott, Andreia Silva, Timothy Robinson, Angelica Santiago-Gómez, Bruno M Simões, Michael Becker, Iduna Fichtner, Ladislav Andera, Philippa Young, Christine Morris, Peter Barrett-Lee, Fouad Alchami, Marco Piva, Maria dM Vivanco, Robert B Clarke, Julia Gee, Richard Clarkson

Synergistic targeting of breast cancer stem-like cells by human γδ T cells and CD8+ T cells

人γδ T细胞和CD8+ T细胞协同靶向乳腺癌干细胞样细胞

Hung-Chang Chen ,Noémie Joalland ,John S Bridgeman ,Fouad S Alchami ,Ulrich Jarry ,Mohd Wajid A Khan ,Luke Piggott ,Yasmin Shanneik ,Jianqiang Li ,Marco J Herold ,Thomas Herrmann ,David A Price ,Awen M Gallimore ,Richard W Clarkson ,Emmanuel Scotet ,Bernhard Moser ,Matthias Eberl

Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL

抑制凋亡抑制剂 c-FLIP 可选择性地消除乳腺癌干细胞对抗癌剂 TRAIL 的活性

Luke Piggott, Nader Omidvar, Salvador Martí Pérez, Rhiannon French, Matthias Eberl, Richard W E Clarkson